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308Outcome and quality of life after endovascular
abdominal aortic aneurysm repair in octogenarians
Robert A. Pol, MD, PhD,a Clark J. Zeebregts, MD, PhD,a Steven M. M. van Sterkenburg, MD,b
Luis M. Ferreira, MD,c Yigit Goktay, MD,d andMichel M. P. J. Reijnen, MD, PhD,b for the Endurant Stent
Graft Natural Selection Global Postmarket Registry (ENGAGE) Investigators, Groningen and Arnhem,
The Netherlands; Buenos Aires, Argentina; and Alsancak, Turkey
Objective: This study determined outcome and quality of life (QOL) in octogenarians, compared with patients
aged <80 years, 1 year after endovascular aortic aneurysm repair (EVAR).
Methods: From March 2009 until April 2011, 1263 patients in the Endurant Stent Graft Natural Selection Global
Postmarket Registry (ENGAGE) registry with an abdominal aortic aneurysm were treated with EVAR using the
Endurant endograft (Medtronic Cardiovascular, Santa Rosa, Calif). The patients were grouped according to those aged
$80 years (290 [22.9%]) and those aged <80 years (973 [77.1%]) at the time of the procedure. QOL was assessed using
composite EuroQoL 5-Dimensions Questionnaire (EQ-5D) index scores. Baseline, perioperative, and follow-up data
were analyzed at 1 year.
Results: Octogenarians had poorer anatomic characteristics. The technical success rate was almost 99% for both cohorts,
with no deaths. The duration of the implant procedure was significantly longer in the elderly patients (P [ .002), with
significant differences in overall (P < .001) and postprocedure (P < .001) hospital stays in favor of the younger group.
At 1 year, there was a significant difference in all-cause mortality (P [ .002) and in the number of major adverse events
(P [ .003), including secondary rupture (P [ .01), to the detriment of octogenarians. There were no significant
differences in conversion to open surgery or in overall secondary endovascular procedures. The octogenarians scored
lower in their overall health care perception (P < .001) but with no significant difference in the EQ-5D index. Compared
with the group aged <80 years, they had still not completely recovered their QOL after 1 year (P [ .01).
Conclusions: Octogenarians are more difficult to treat by EVAR than younger patients due to poorer anatomic suitability
and a higher incidence of complications. Recovery of QOL in octogenarians takes longer (>12 months) than expected.
(J Vasc Surg 2014;60:308-17.)Globally, there is a growing aging population in indus-
trialized countries. In the United States, the cohort of oc-
togenarians is increasing by as many as 160,000 persons per
year.1 Inevitably, this results in more elderly patients pre-
senting with abdominal aortic aneurysms (AAAs) that
need treatment. Because open AAA repair in this age group
is associated with high morbidity and mortality rates, endo-
vascular AAA repair (EVAR) is now considered the gold
standard in these frail patients.2-7 Although the feasibility
of EVAR in octogenarians has been shown, possible effects
on quality of life (QOL) must also be considered. Even
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://dx.doi.org/10.1016/j.jvs.2014.02.009such as mobility and self-care can be of critical importance
in these vulnerable patients.
The Endurant Stent Graft Natural Selection Global
Postmarket Registry (ENGAGE) is a multicenter, nonin-
terventional, nonrandomized, single-arm prospective
study of the Endurant endograft device (Medtronic Car-
diovascular, Santa Rosa, Calif).8 In our previous report
on the 30-day outcomes in patients aged #80 years
compared with those >80 years, most parameters were
similar between the two age groups but recovery of
QOL measures appeared to occur sooner in those patients
aged <80 years.9 Although the 30-day outcome is a good
measure for recovery after EVAR, the 1-year data, which
we will describe in this report, will provide a more reliable
representation and show whether full rehabilitation occurs
in this group.
METHODS
The study population included consecutive patients
who were enrolled in the ENGAGE registry from 79
sites in Western, Central and Eastern Europe, Asia,
South Africa, the Middle East, Latin America, and Can-
ada. The patients were divided into two groups: those
aged >80 years (290 [22.9%]) and those #80 years
(973 [77.1%]) at the time of the procedure. The study
is registered on clinicaltrials.gov (NCT00870051). In-
formation on study design, protocol-defined inclusion
criteria, the Endurant stent graft system, data collection,
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previously.8,9
Briefly, the preoperative risk assessment consisted of
the American Society of Anesthesiologists Physical Status
Classification and the Society for Vascular Surgery/Inter-
national Society of Vascular Specialists (SVS/ISVS) score.
Baseline comorbidities (hypertension, hyperlipidemia,
diabetes, cancer, cardiac disease, tobacco use, renal insuffi-
ciency) and anatomic characteristics of the aneurysm
(aneurysm diameter, length of nonaneurysmal neck, prox-
imal and distal neck diameter, iliac artery diameters, and
infrarenal neck angle) were tabulated.
Perioperative outcome data included the technical suc-
cess of stent graft placement (defined by successful intro-
duction of the delivery system and deployment of the
device) and freedom from intraoperative death or type
I/III endoleak. Successful delivery and deployment of
the stent graft was defined as deployment of the Endurant
Stent Graft System in the planned location, with no unin-
tentional coverage of both internal iliac arteries or any
visceral aortic branches, and with the removal of the deliv-
ery system. Successful implantation was defined as the
absence of stent kinking or twisting, suprarenal bare stent
fracture, or stent graft malfunction, including type I or
IV endoleak.
Measures assessed after discharge included freedom
from migration, graft occlusion, loss of structural integrity,
endoleak, aneurysm expansion, major adverse device-
related effects, and all-cause mortality.
QOL was assessed using the EuroQoL 5-Dimensions
Questionnaire (EQ-5D) index score, a preference-based,
generic instrument that measures QOL in three different
ways.10,11 The first part is a descriptive system profiling a
respondent’s health status in five dimensions: mobility,
self-care, usual activities, pain/discomfort, and anxiety/
depression. Reporting is on a scale of 1 (no problems)
to 3 (extreme problems). The second measure is a 0 to
100 visual analog scale for self-rating of a patient’s
own health. The last measure, the “composite EQ-5D
index,” reflects the utility of the measured health profile
from the perspective of the general population. Ratings
took place at the first contact (baseline), at discharge,
and at the 30-day and 1-year outpatient visits. Differ-
ences were measured at these assessments, comparing
values between groups at each time point and within
groups between baseline and each of the postoperative
time points.
Statistical analysis. Differences between continuous
variables were tested with the two-tailed Student t-test,
except for hospital stay, procedural stay, and intensive care
unit time, where the Wilcoxon rank sum test was applied.
Normally distributed continuous variables are expressed as
mean 6 standard deviation, and skewed variables are
expressed as median and interquartile range. For categoric
data, the Cochran-Mantel-Haenszel test was used. Two-
tailed P values were used throughout, and significance
was assumed when the P value was <.05. All statisticalanalyses were performed with SAS 9.13 software (SAS
Institute, Carey, NC).
RESULTS
FromMarch 2009 until April 2011, 1263 patients with
infrarenal AAA were enrolled in the ENGAGE registry and
treated with the Endurant endograft. Baseline characteris-
tics are reported in Table I. The mean age was 70.1 6
6.5 years (range, 43-79 years) in patients <80 years (n ¼
973) and 83.3 6 2.9 years (range, 80-93 years) in patients
aged $80 years (n ¼ 290). Sex distribution was skewed,
with significantly more women in the octogenarian cohort
(P ¼ .039). The frequency of tobacco use (P # .001) and
alcoholism (P ¼ .006) was higher in the group
aged <80 years. The overall incidence of cardiac disease
was equally distributed, despite the presence of more ar-
rhythmias in the octogenarian cohort (P ¼ .004). During
the preoperative assessment, renal insufficiency (P ¼ .01)
was more common in patients aged $80 years, whereas
liver disease was more prevalent among younger patients
(P ¼ .01). Octogenarians had significantly higher American
Society of Anesthesiologists classifications (P < .001) and
SVS/ISVS scores (P < .001).
Anatomic characteristics. The primary indication for
endograft implant differed between the two groups. Octo-
genarians had larger aneurysms (61.9 6 11.3 vs 59.8 6
11.7 mm), and the younger patients had more rapidly
growing aneurysms (7.1% [69 of 973] vs 3.4% [10 of
290]; P ¼ .037). Furthermore, octogenarians had signifi-
cantly greater infrarenal neck angulation (33.2 6 24.0
vs 29.5 6 23.6; P ¼ .02) and larger left iliac arteries
(14.2 6 3.5 vs 13.6 6 3.5 mm; P ¼ .03; Table II).
Procedural data and hospital stay. A preimplant
adjunctive procedure (ie, coil embolization of internal iliac
or inferior mesenteric artery) was more frequently required
in the patients aged <80 years (P ¼ .04; Table III). The
type of anesthesia used was similar in both groups. The
duration of implant procedure was significantly longer in
the elderly group (106.7 6 42.5 vs 97.3 6 45.5 minutes;
P ¼ .002), and they also had slightly more blood loss
(230.5 6 244.7 vs 201.4 6 211.8 mL; P ¼ .05). There
were no differences regarding arterial access entry site of
the main body (P ¼ .86) or contralateral limb (P ¼ .80).
However, there was a significant difference with respect to
the number of distal graft extensions that were needed in
favor of the younger patients (P < .001).
Although the volume of contrast was similar in the two
groups (P ¼ .77), the total fluoroscopy time was longer in
the octogenarian cohort (22.0 6 13.6 vs 20.1 6 11.9 mi-
nutes, P ¼ .03). The numbers of additional devices used or
associated procedures performed during implant procedure
were similar. The Endurant endograft was inserted and
deployed with equal success in both groups (P ¼ .606).
There were significant differences in overall (P < .001)
and postprocedure hospital stays (P < .001) in favor of
the younger group (Table III). Admittance to (35% vs
35%) and duration of intensive care unit stay (10.7 vs
Table I. Baseline and anatomic characteristics, risk factors, and comorbidity
Baseline characteristicsa Age <80 years (n ¼ 973)b Age $80 years (n ¼ 290)b Pc
Age, years 70.1 6 6.5 83.3 6 2.9 NA
Sex .04
Female 9.6 (93/973) 13.8 (40/290)
Male 90.4 (880/973) 86.2 (250/290)
Primary indication for implant .04
Aneurysm diameter
$1.5 normal infrarenal aorta 3.7 (36/973) 1.7 (5/290)
4-5 cm ($0.5 cm increase in last 6 months) 7.1 (69/973) 3.4 (10/290)
>5 cm 86.7 (844/973) 92.8 (269/290)
Other 2.5 (24/973) 2.1 (6/290)
Baseline symptoms
None 83.4 (811/973) 85.5 (248/290) .379
Abdominal pain 10.8 (105/973) 10.3 (30/290) .829
Back pain 5.8 (56/973) 3.4 (10/290) .121
Other 2.4 (23/973) 2.8 (8/290) .703
Risk factors
Tobacco use 56.5 (538/952) 24.6 (69/280) <.001
Hypertension 75.9 (728/959) 73.9 (212/287) .480
Hyperlipidemia 62.4 (574/920) 53.9 (145/269) .012
Diabetes mellitus 19.9 (191/958) 15.7 (45/287) .107
Cancer 19.9 (191/960) 22.3 (63/282) .371
Alcoholism 4.0 (38/947) 0.7 (2/282) .006
Cardiac disease 53.0 (515/972) 55.2 (160/290) .512
Arrhythmia 14.4 (137/951) 21.5 (61/284) .004
Pulmonary disease 25.1 (240/955) 25.4 (73/287) .917
Renal insufficiency 13.9 (134/963) 20.1 (58/289) .011
Carotid artery disease 10.8 (87/808) 11.3 (28/247) .802
Cerebrovascular/neurologic disease 11.7 (114/972) 15.9 (46/290) .063
Vascular disease 30.8 (299/972) 31.4 (91/290) .842
Liver disease 2.9 (28/972) 0.3 (1/290) .011
ASA classification <.001
I 7.1 (69/972) 2.8 (8/290)
II 43.6 (424/972) 35.5 (103/290)
III 39.4 (383/972) 48.6 (141/290)
IV 9.9 (96/972) 13.1 (38/290)
SVS/ICVS Risk Level <.001
0 0.1 (1/934) 0.0 (0/283)
1 17.8 (166/934) 0.0 (0/283)
2 66.4 (620/934) 0.0 (0/283)
3 15.7 (147/934) 100.0 (283/283)
ASA, American Society of Anesthesiologists; NA, not applicable; SVS/ISVS, Society for Vascular Surgery/International Society of Vascular Specialists.
aContinuous data are presented as mean 6 standard deviation and categoric data as percentage (counts/n).
bn ¼ number of intention-to-treat patients with nonmissing values. One patient can report more than one baseline symptom; hence, sum of all the counts can
be more than the denominator.
cP values #.05 were considered statistically significant.
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initial implantation success. Endograft twisting (P ¼ .01)
and perioperative type I endoleak (corrected; P < .001)
were more frequently observed in the octogenarian group.
After correction of the endoleak during the same proce-
dure, there was no longer a difference in this incidence of
type I endoleak between the two groups (P ¼ .618). There
was no difference regarding deviation from instructions for
use (Table IV).
Adverse events. During follow-up, a significant
discrepancy in major adverse events (MAEs) was evident
between the two age groups. Whereas there was no dif-
ference in MAE incidence at 30 days,9 a significant differ-
ence regarding all-cause mortality (P ¼ .002) and the
number of MAEs (P ¼ .003) was observed after 1 year(Fig 1). No single MAE category accounted for the dif-
ference; however, myocardial infarctions occurred in the
octogenarian cohort at twice the frequency of younger
patients. In addition, twice as many secondary endovas-
cular procedures were necessary to correct type I/III
endoleak in this group, although the difference did not
reach significance. After 1 year, this resulted in a significant
difference in the aneurysm rupture rate to the detriment of
octogenarians (0% vs 0.7%; P ¼ .01). There was no sig-
nificant difference regarding conversion to open surgery
(P ¼ .58) or performance of overall secondary endovas-
cular procedures (P ¼ .34; Table V; Fig 2).
QOL assessments. Table VI reports the QOL data
between groups at each of the time points (intergroup
differences) and within each group from the preoperative
Table II. Anatomic details
Aneurysm measurementsa Age <80 years (n ¼ 973) Age $80 years (n ¼ 290) Pb
Diameter
Aneurysm, mm 59.8 6 11.7 61.9 6 11.3 .007
Proximal neck, mm 23.7 6 3.6 23.8 6 3.5 .912
Distal neck, mm 24.9 6 4.1 24.9 6 4.0 .844
Length of nonaneurysmal aortic neck, mm 26.9 6 12.4 27.3 6 12.3 .693
Distal diameter of nonaneurysmal neck of
Right iliac artery, mm 14.0 6 3.5 14.5 6 3.7 .071
Left iliac artery, mm 13.6 6 3.5 14.2 6 3.5 .035
Infrarenal neck angle,  29.5 6 23.6 33.2 6 24.0 .021
aData are presented as mean 6 standard deviation.
bP values #.05 were considered statistically significant.
Table III. Initial procedural data and hospital stay
Variablea Age <80 years (n ¼ 926) Age $80 years (n ¼ 274) Pb
Preimplant adjunctive procedure 8.4 (82/973) 4.8 (14/290) .042
Coil embolization of
Hypogastric artery 4.6 (45/973) 3.1 (9/290) .261
Inferior mesenteric artery 1.3 (13/973) 0.3 (1/290) .157
Other procedure 2.7 (26/973) 1.4 (4/290) .205
Type of anesthesia
General 60.8 (592/973) 66.8 (193/289) .068
Spinal 21.9 (213/973) 18.7 (54/289) .241
Epidural 8.5 (83/973) 6.6 (19/289) .284
Local 13.6 (132/973) 12.1 (35/289) .522
Extension <.001
Left femoral 14.3 (139/972) 11.4 (33/290)
Left iliac 1.9 (18/972) 2.8 (8/290)
Right femoral 18.2 (177/972) 25.2 (73/290)
Right iliac 0.6 (6/972) 3.1 (9/290)
Other 22.3 (217/972) 22.8 (66/290)
NA 42.7 (415/972) 34.8 (101/290)
Duration of implant procedure, min 97.3 6 45.5 106.7 6 42.5 .002
>1 SD compared with the mean, 45 min 93.5 (901/964) 98.3 (283/288) .002
>2 SD compared with the mean, 45 min 52.2 (503/964) 64.9 (187/288) .001
Estimated blood loss during procedure, mL 201.4 6 211.8 230.5 6 244.7 .051
Total fluoroscopic time, min 20.1 6 11.9 22.0 6 13.6 .026
Evaluation of Endurantc 99.0 (963/973) 99.3 (287/289) .606
Endograft successfully delivered 99.4 (967/973) 99.7 (289/290) .584
Endograft successfully deployed 99.4 (967/973) 99.7 (289/290) .584
Endograft covered internal iliac arteries or any visceral
aortic branches unintentionally
0.5 (5/971) 0.3 (1/289) .714
Length of stay
Overall hospital,d days 6.2 6 6.6 7.6 6 6.2 <.001
Procedural,e days 4.55 6 4.91 5.75 6 5.50 <.001
Intensive care unit, hours 10.7 6 47.6 8.0 6 17.0 .816
Intraoperative clinical success 97.5 (949/973) 97.9 (283/289) .702
Technical success 99.0 (963/973) 99.3 (287/289) .606
Freedom from intraoperative death 100.0 (973/973) 100.0 (290/290) NA
Freedom from type I/III endoleak (uncorrected) 98.6 (954/968) 98.6 (285/289) .938
NA, Not applicable.
aContinuous data are presented as mean 6 standard deviation and categoric data as percentage (count/n).
bP values #.05 were considered statistically significant.
cMedtronic Cardiovascular, Santa Rosa, Calif.
dCalculated as the date of hospital dischargee date of hospital admission.When the two dates were the same, the overall hospital stay was considered to be 0.5 day.
eCalculated as the date of hospital discharge e date of initial procedure. When the two dates were the same, the procedural hospital stay was considered to be
0.5 day.
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differences). At baseline, the two groups scored the same
in most dimensions except for mobility (P ¼ .03) and
self-care (P < .001), which is to be expected. Although thisdid not reach a significant intergroup difference, at the time
of hospital discharge, both groups scored themselves lower
in the dimensions of mobility, self-care, usual activity, and
pain/discomfort. Only the dimension of usual activity was
Table IV. Initial endograft outcome
Event Age <80 years (n ¼ 968), % (count/n) Age $80 years (n ¼ 289), % (count/n) Pa
Endograft kinking 0.9 (9/966) 1.4 (4/288) .502
Endograft twisting 0.2 (2/965) 1.4 (4/288) .011
Endograft wire fracture 0.0 (0/966) 0.0 (0/288) NA
Suprarenal bare stent fracture 0.0 (0/966) 0.0 (0/288) NA
Additional endograft malfunction(s) 0.3 (3/968) 0.3 (1/289) .924
Endoleak (corrected) 7.7 (75/968) 13.8 (40/289) .002
Type I 4.5 (44/968) 11.4 (33/289) <.001
Type II 1.9 (18/968) 2.1 (6/289) .819
Type III 1.2 (12/968) 0.3 (1/289) .188
Type IV 0.1 (1/968) 0.0 (0/289) .585
Undetermined 0.1 (1/968) 0.3 (1/289) .364
Endoleak (uncorrected) 15.2 (147/968) 19.0 (55/289) .118
Type I 1.0 (10/968) 1.4 (4/289) .618
Type II 11.7 (113/968) 15.2 (44/289) .110
Type III 0.4 (4/968) 0.0 (0/289) .274
Type IV 1.4 (14/968) 2.8 (8/289) .133
Undetermined 0.9 (9/968) 0.0 (0/289) .100
Treated outside IFU 18.2 (117/973) 16.9 (49/290) .614
IFU, Instructions for use; NA, not applicable.
aP values #.05 were considered statistically significant.
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the octogenarian cohort, compared with the patients
aged <80 years, still experienced problems in mobility
(P < .001), self-care (P < .001), usual activity (P < .001),
and in perception of pain and discomfort (P ¼ .001). A
small intragroup improvement was noted regarding
mobility, pain/discomfort, and anxiety/depression in the
octogenarian cohort. Improvements in the younger cohort
were seen in the dimensions self-care, pain/discomfort,
and anxiety/depression. At 1 year, octogenarians scored
lower in their overall health care perception (P < .001) but
did not have a significant difference in EQ-5D index.
However, unlike the group aged <80 years, complete re-
covery was not observed in the octogenarian group after
1 year (P ¼ .014). This difference was not visible in
the period between discharge and the 1-year follow-up
(P ¼ .160); thus, the impairment must have occurred
during hospital stay/surgery.DISCUSSION
The technical success rates of EVAR in octogenarians
in initial endograft placement and outcome are high
(99.3%); however, the procedure has important implica-
tions with respect to overall mortality, aneurysm rupture,
and QOL. The higher number of additional procedures
(preimplant, graft extensions, and endoleak corrections),
the prolonged duration of surgery, increased blood loss,
and extended hospital stay should also be taken into
account. Although a certain risk may be justifiable, even
in as vulnerable a group as octogenarians, this study shows
that EVAR also has implications for recovery and preserva-
tion of QOL. Marked improvements occur in a number of
domains, but recovery is still not complete in mobility, self-
care, and usual activities in octogenarians after 1 year,suggesting that the effect of EVAR is greater in octogenar-
ians than previously thought.
As noted in our previous report on 30-day outcome,
octogenarians have a similar initial endograft outcome in
overall terms, despite the aberrant anatomy, compared
with the younger cohort. The anatomic differences did
not lead to a lower technical success rate or an increased
need for early secondary interventions #30 days, and
this was unchanged after 1 year. Nevertheless, the signif-
icant difference in aneurysm rupture rates is, at the very
least, an alarming and troubling finding. Given that the
overall distribution of comorbidities is similar in both
groups, except in some cardiovascular risk factors, the dif-
ferences in anatomic characteristics described in Table II
may be determinative. Together with the larger aneurysm
diameters, this has to be considered a risk factor for late
rupture.
In general, practitioners are reluctant to offer aneurysm
surgery to elderly patients because the risk of aneurysm
rupture is sometimes difficult to balance against the surgical
risk. This must be weighed against the natural, and often
limited, life expectancy of octogenarians. Previous publica-
tions, including those from our clinic, have shown that
EVAR is and remains the treatment of choice in octogenar-
ians because the short-term benefits have been especially
substantial.3-6,12-16 But despite these advantages and the
high procedural success in this specific patient group, the
periprocedural and postprocedural morbidity and mortality
are higher than that of their younger counterparts. This dif-
ference is even greater after emergency surgery and open
AAA repair.6,17
Our series found a significant difference in all-cause
mortality at 1 year to the detriment of the octogenarians.
This is mainly determined by the higher rate of myocardial
infarctions (3.2%) and secondary aneurysm ruptures in the
Fig 1. Probability of survival according to the Kaplan-Meier method after endovascular aneurysm repair (EVAR) in
patients aged $80 years (blue line) compared with patients aged <80 years (red line).
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 2 Pol et al 313elderly patients. Because all patients in the octogenarian
group were classified SVS/ISVS 3, the difference in fatal
cardiac events is not a surprising result and appears
independent of surgery. However, a higher incidence of
aneurysm rupture after EVAR is an outcome more
commonly reported in the literature. A large systematic re-
view andmeta-analysis reported a significantly higher rate of
aortic rupture after EVAR compared with open repair (odds
ratio, 5.94; P < .001).18 In addition, the deviant and chal-
lenging anatomy in elderly patients carries a higher risk of
type I endoleak, with a subsequent increased risk of late
rupture.19,20 In the present study, we found a higher inci-
dence of perioperative type I endoleak in the octogenarians.
This difference disappeared after perioperative correction;
thus, type I endoleak did not seem to be attributed to the
higher incidence of aneurysm rupture in the octogenarians.
The difference in late ruptures cannot be ignored but should
be placed into perspective, because a difference of the twoevents is negligible in daily practice and is presumably supe-
rior to no repair. EVAR offers an important benefit over
open repair in elderly patients, with significantly less major
systemic morbidity than open repair.
Interestingly, the perioperative death rate of both pro-
cedures in this age category is virtually the same.5 This is a
striking difference from studies that describe EVAR and
open repair results in patients of all ages, in which EVAR
demonstrates a lower 30-day mortality.21 It indicates that
the outcome of aneurysm surgery in this vulnerable group
is independent of the type of surgery.
The length of recovery to baseline functional level and
QOL attains particular importance in octogenarians with
their limited life expectancy. We had expected, from the
30-day data, that recovery would have occurred much
sooner. Although QOL is decreased after AAA repair,
EVAR would logically provide an advantage over open sur-
gery. The literature, however, demonstrates precisely the
Table V. Major adverse events (MAEs) within 1 year
Event
Age <80 years (n ¼ 963),
% (count/n)
Age $80 years (n ¼ 283),
% (count/n) Pa
All-cause mortality 6.2 (60/963) 11.7 (33/283) .002
$1 MAEs 9.9 (95/963) 16.3 (46/283) .003
Bowel ischemia 0.2 (2/963) 0.4 (1/283)
Myocardial infarction 1.7 (16/963) 3.2 (9/283)
Paraplegia 0.0 (0/963) 0.0 (0/283)
Renal failure 1.0 (10/963) 1.4 (4/283)
Respiratory failure 0.1 (1/963) 0.0 (0/283)
Stroke 0.5 (5/963) 0.4 (1/283)
Aneurysm-related
Conversion to open surgery 0.6 (6/973) 0.3 (1/290) .58
Aneurysm rupture 0.0 (0/973) 0.7 (2/290) .01
Secondary endovascular procedure 6.0 (58/973) 4.5 (13/290) .34
Secondary endovascular procedure to correct type I/III endoleak 1.1 (11/973) 2.4 (7/290) .11
aP values #.05 were considered statistically significant.
Fig 2. Probability of intervention-free survival according to the Kaplan-Meier method after endovascular aneurysm
repair (EVAR) in patients aged $80 years (blue line) compared with patients aged <80 years (red line).
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Table VI. Outcome of activities of daily living and quality of life (QOL)
Variablea Age <80 years (n ¼ 973) Age $80 years (n ¼ 290) Pb
Baseline
Mobility .033
1 (no problem) 71.1 (663/932) 63.8 (176/276)
2 (some problems) 28.1 (262/932) 35.9 (99/276)
3 (extreme problems) 0.8 (7/932) 0.4 (1/276)
Self-care <.001
1 (no problem) 92.5 (862/932) 84.1 (232/276)
2 (some problems) 6.4 (60/932) 14.1 (39/276)
3 (extreme problems) 1.1 (10/932) 1.8 (5/276)
Usual activities .094
1 (no problem) 81.7 (761/932) 76.4 (211/276)
2 (some problems) 16.0 (149/932) 21.0 (58/276)
3 (extreme problems) 2.4 (22/932) 2.5 (7/276)
Pain/discomfort .964
1 (no problem) 65.1 (607/932) 64.5 (178/276)
2 (some problems) 31.9 (297/932) 33.0 (91/276)
3 (extreme problems) 3.0 (28/932) 2.5 (7/276)
Anxiety/depression .212
1 (no problem) 71.6 (667/932) 75.4 (208/276)
2 (some problems) 25.2 (235/932) 22.1 (61/276)
3 (extreme problems) 3.2 (30/932) 2.5 (7/276)
Your own health state today (0, bad; 100, excellent) 73.1 6 16.5 73.0 6 16.2 .909
Median (IQR) 75 (64-85) 75 (63-80)
EQ-5D Index 0.86 6 0.17 0.85 6 0.17 .372
Median (IQR) 0.84 (0.81-1.00) 0.84 (0.79-1.00)
At discharge
Mobility .068
1 (no problem) 56.4 (457/811) 50.2 (118/235)
2 (some problems) 42.2 (342/811) 47.2 (111/235)
3 (extreme problems) 1.5 (12/811) 2.6 (6/235)
Self-care .092
1 (no problem) 76.3 (618/810) 72.3 (170/235)
2 (some problems) 22.3 (181/810) 24.3 (57/235)
3 (extreme problems) 1.4 (11/810) 3.4 (8/235)
Usual activities .043
1 (no problem) 62.1 (504/811) 53.6 (126/235)
2 (some problems) 31.7 (257/811) 39.6 (93/235)
3 (extreme problems) 6.2 (50/811) 6.8 (16/235)
Pain/discomfort .527
1 (no problem) 46.3 (375/810) 43.8 (103/235)
2 (some problems) 51.2 (415/810) 53.6 (126/235)
3 (extreme problems) 2.5 (20/810) 2.6 (6/235)
Anxiety/depression .863
1 (no problem) 81.2 (658/810) 81.3 (191/235)
2 (some problems) 17.7 (143/810) 17.0 (40/235)
3 (extreme problems) 1.1 (9/810) 1.7 (4/235)
Your own health state today (0, bad; 100, excellent) 72.3 6 15.8 70.1 6 16.7 .076
Median (IQR) 74 (60-84) 70 (60-80)
EQ-5D Index 0.81 6 0.18 0.79 6 0.18 .085
Median (IQR) 0.83 (0.75-1.00) 0.81 (0.71-1.00)
Change in EQ-5D from baseline to discharge e0.05 6 0.17 0.06 6 0.17 .492
Median (IQR) 0 (e0.16 to 0) 0 (e0.16 to 0)
After 12 months
Mobility <.001
1 (no problem) 70.9 (524/739) 57.9 (114/197)
2 (some problems) 28.3 (209/739) 41.6 (82/197)
3 (extreme problems) 0.8 (6/739) 0.5 (1/197)
Self-care <.001
1 (no problem) 93.9 (694/739) 81.2 (160/197)
2 (some problems) 5.4 (40/739) 16.2 (32/197)
3 (extreme problems) 0.7 (5/739) 2.5 (5/197)
Usual activities <.001
1 (no problem) 81.5 (602/739) 68.5 (135/197)
2 (some problems) 16.2 (120/739) 29.4 (58/197)
3 (extreme problems) 2.3 (17/739) 2.0 (4/197)
(Continued on next page)
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Table VI. Continued.
Variablea Age <80 years (n ¼ 973) Age $80 years (n ¼ 290) Pb
Pain/discomfort .001
1 (no problem) 75.9 (561/739) 67.0 (132/197)
2 (some problems) 22.6 (167/739) 27.4 (54/197)
3 (extreme problems) 1.5 (11/739) 5.6 (11/197)
Anxiety/depression .342
1 (no problem) 84.6 (625/739) 82.2 (162/197)
2 (some problems) 14.2 (105/739) 15.7 (31/197)
3 (extreme problems) 1.2 (9/739) 2.0 (4/197)
Your own health state today (0, bad; 100, excellent) 78.8 6 15.5 74.1 6 17.1 <.001
Median (IQR) 80 (70-90) 75 (62.5-90)
EQ-5D Index 0.90 6 0.15 0.84 6 0.19 .083
Median (IQR) 1.00 (0.83-1.00) 0.85 (0.78-1.00)
Change in EQ-5D from baseline to 12 months 0.03 6 0.17 0.00 6 0.17 .014
Median (IQR) 0 (0-0.16) 0 (e0.06 to 0.06)
Change in EQ-5D from discharge to 12 months 0.07 6 0.18 0.05 6 0.19 .160
Median (IQR) 0.04 (0-0.17) 0.04 (0-0.17)
EQ-5D, EuroQoL 5-Dimensions Questionnaire; IQR, interquartile range.
aCategoric data are presented as percentage (count/n) and continuous data as mean 6 standard deviation, unless stated otherwise.
bP values #.05 were considered statistically significant.
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follow-up in favor of open repair.22,23 In addition, a recent
study showed that the recovery time after AAA surgery for
all ages is at least 12 months24; therefore, that recovery
time would be even more prolonged for octogenarians
seems logical.
Changes in QOL depend strongly on preoperative in-
formation disclosure and patient expectations. Providing
proper information goes beyond procedure-related mortal-
ity and morbidity but should also provide the patient with
more awareness on preservation and loss in QOL after sur-
gery. The current results show that recovery in QOL and
the domains of “mobility” and “usual activity” is delayed
longer than expected. Providing more awareness is prob-
ably more important than previously thought and may
even contribute to a faster recovery.
This study has some limitations. Despite the limited in-
clusion and exclusion criteria of the registry, all patients
included were suitable for AAA repair with an endovascular
endograft. In addition, we describe the outcomes after
elective surgery. Although the results in QOL are likely
to be the same after emergency surgery, there is a known
difference in the occurrence of complications. Also, there
is a known interplay of advanced age and technical chal-
lenging anatomy in the literature. Even though the re-
ported differences are undoubtedly age-related, they may
be slightly distorted by differences in anatomy. Various pa-
tients were lost to follow-up, which this could have led to
some form of selection bias, especially for assessing overall
health and QOL.
The strength of our study of these 1263 patients is the
precision of estimates of the incidence of adverse effects.
The weakness of such a large cohort is that statistically sig-
nificant differences may be found that have little clinical
significance; for example, the small differences in blood
loss, duration of implant procedure, or fluoroscopic timehave no significance in everyday practice. We are aware of
this problem, but given the consequences of, for instance,
AAA rupture, considered it important enough to mention.
The greater rate of mortality at 1 year can be at least partly
attributed to the older age of the group. To suggest or
demonstrate that it is related to EVAR, one would need
to compare it to population-based data. We left that out
of consideration in the current report.
CONCLUSIONS
EVAR can safely be performed in octogenarians, albeit
with aberrant anatomy requiring more femoral or iliac ex-
tensions and with a higher incidence of complications,
including rupture. The effect on QOL and recovery to
baseline functioning, however, is greater in octogenarians
and seems to last at least >1 year.
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